Researchers have found that a molecule long believed to be a beneficial tumor suppressor — and thus a potential cancer drug target — appears to act as an oncogene in some lethal brain tumors.
Researchers have found that a molecule long believed to be a beneficial tumor suppressor — and thus a potential cancer drug target — appears to act as an oncogene in some lethal brain tumors.